Request Free Sample ×
Blood Grouping Reagents Market Research Report - Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Blood Grouping Reagents Market

ID: MRFR/HC/9241-CR
142 Pages
Rahul Gotadki
Last Updated: May 15, 2026
Blood Grouping Reagents Market Research Report: Size, Share, Trend Analysis By Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), By End Users (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Blood Grouping Reagents Market Infographic
Summary Table of Contents Segmentation Methodology Download PDF

Blood Grouping Reagents Market Summary

According to MRFR analysis, the Blood Grouping Reagents Market Size was valued at USD 2.09 Million in 2024. The market is projected to grow from USD 2.27 Million in 2025 to USD 4.63 Million by 2035, registering a CAGR of 7.47% during the forecast 2025–2035. North America led the market with over 53% share, generating around USD 1.1 Million in revenue.

Key Market Trends & Highlights

The Blood Grouping Reagents Market is poised for substantial growth driven by technological advancements and increasing demand for blood safety.

  • North America remains the largest market for blood grouping reagents, driven by advanced healthcare infrastructure and regulatory compliance.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and increasing blood donation initiatives.
  • Blood typing continues to dominate the market, while the transfusion medicine segment is experiencing rapid growth due to heightened awareness of blood safety.
  • Key market drivers include technological innovations in blood grouping reagents and the expansion of healthcare infrastructure, which are likely to enhance market dynamics.

Market Size & Forecast

2024 Market Size 2.09 (USD Million)
2035 Market Size 4.63 (USD Million)
CAGR (2025 - 2035) 7.47%

Major Players

Grifols (ES), Roche (CH), Abbott (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Beckman Coulter (US), Merck KGaA (DE), Siemens Healthineers (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Blood Grouping Reagents Market Trends

The Blood Grouping Reagents Market is currently experiencing a dynamic evolution, driven by advancements in technology and increasing demand for accurate blood typing. The growing prevalence of blood transfusions and organ transplants necessitates reliable reagents for effective blood grouping. Furthermore, the rise in awareness regarding blood safety and compatibility is propelling the market forward.

As healthcare systems worldwide prioritize patient safety, the need for high-quality reagents becomes paramount. This trend is further supported by ongoing research and development efforts aimed at enhancing the efficiency and accuracy of blood grouping processes. In addition, the Blood Grouping Reagents Market is witnessing a shift towards automation and integration of digital technologies.

Laboratories are increasingly adopting automated systems to streamline operations and reduce human error. This transition not only improves efficiency but also enhances the overall quality of testing. Moreover, the expansion of healthcare infrastructure in emerging economies is likely to create new opportunities for market players. As these regions invest in modernizing their healthcare facilities, the demand for reliable blood grouping reagents is expected to rise, indicating a promising outlook for the market in the coming years.

Technological Advancements

The Blood Grouping Reagents Market is influenced by continuous technological innovations. New methodologies and automated systems are being developed to enhance the accuracy and speed of blood typing processes. These advancements are likely to improve laboratory efficiency and reduce the potential for human error.

Increased Demand for Blood Safety

Growing awareness regarding the importance of blood safety is driving the Blood Grouping Reagents Market. As healthcare providers emphasize the need for compatibility in transfusions and transplants, the demand for reliable reagents is expected to rise, ensuring patient safety.

Expansion in Emerging Markets

Emerging economies are witnessing significant growth in healthcare infrastructure, which is likely to impact the Blood Grouping Reagents Market positively. As these regions invest in modern medical facilities, the need for effective blood grouping solutions is anticipated to increase, presenting new opportunities for market participants.

Blood Grouping Reagents Market Drivers

Regulatory Support for Blood Safety

Regulatory bodies worldwide are increasingly emphasizing the importance of blood safety, which significantly impacts the Global Blood Grouping Reagents Market Industry. Stringent regulations regarding blood testing and safety protocols necessitate the use of high-quality reagents for accurate blood typing.
 
Compliance with these regulations ensures that healthcare providers can deliver safe transfusions, thereby enhancing patient outcomes. As regulations evolve, the market is likely to adapt, leading to innovations in reagent development. This regulatory landscape not only supports market growth but also reinforces the commitment to patient safety in transfusion practices.

Rising Demand for Blood Transfusions

The Global Blood Grouping Reagents Market Industry experiences a notable increase in demand for blood transfusions, driven by a growing prevalence of chronic diseases and surgical procedures. As healthcare systems worldwide expand their capabilities, the need for accurate blood typing becomes paramount. In 2024, the market is projected to reach 0.11 USD Billion, reflecting the urgency for reliable reagents in transfusion medicine. This trend is expected to continue, with the market adapting to the rising number of transfusions required annually, thereby enhancing the overall efficiency of blood banks and hospitals.

Increasing Awareness of Blood Donation

The Global Blood Grouping Reagents Market Industry benefits from heightened awareness regarding the importance of blood donation. Campaigns aimed at educating the public about the need for diverse blood types have led to increased participation in blood donation drives.
 
This surge in donations necessitates the use of effective blood grouping reagents to ensure compatibility and safety. As more individuals engage in donating blood, the demand for reliable reagents is expected to rise, thereby supporting the growth of the market. This trend underscores the critical role of education in fostering a culture of donation.

Market Challenges and Declining Growth Rates

Despite the growth potential, the Global Blood Grouping Reagents Market Industry faces challenges that may hinder its expansion. Projections indicate a compound annual growth rate (CAGR) of -29.29% for the period from 2025 to 2035, suggesting a decline in market activity.
 
 Factors contributing to this trend may include saturation in certain regions and the emergence of alternative technologies. As the market navigates these challenges, stakeholders must adapt their strategies to maintain relevance and ensure sustainability in a rapidly changing healthcare landscape.

Technological Advancements in Blood Grouping

Technological innovations play a crucial role in shaping the Global Blood Grouping Reagents Market Industry. The introduction of automated blood grouping systems and advanced reagents enhances accuracy and reduces turnaround times in blood typing processes. These advancements not only improve patient safety but also streamline laboratory workflows.
 
As healthcare facilities increasingly adopt these technologies, the market is likely to witness a surge in demand for high-quality reagents. This trend indicates a shift towards more sophisticated blood grouping solutions, which could potentially lead to a more efficient healthcare delivery system.

Market Segment Insights

By Application: Blood Typing (Largest) vs. Transfusion Medicine (Fastest-Growing)

In the Blood Grouping Reagents Market, the application segment is primarily dominated by Blood Typing, which accounts for a significant share of the market, indicating its established presence in laboratories and hospitals. Transfusion Medicine follows as the fastest-growing segment, driven by increasing awareness and advancements in healthcare technologies that enhance blood transfusion safety and efficacy. As healthcare facilities adopt these technologies, the market landscape continues to evolve toward more reliable blood grouping solutions.

Blood Typing (Dominant) vs. Transfusion Medicine (Emerging)

Blood Typing has emerged as the dominant application in the market share due to its critical role in clinical diagnostics and blood banking processes. This segment is integral for ensuring compatibility between donors and recipients, thus preventing adverse transfusion reactions. On the other hand, Transfusion Medicine represents an emerging area fueled by innovative practices and a growing emphasis on patient safety. As healthcare providers ramp up their efforts to optimize transfusion processes and minimize risks, Transfusion Medicine is rapidly gaining traction, reflecting a shift towards more comprehensive and advanced medical solutions in blood management.

By End Use: Hospitals (Largest) vs. Blood Banks (Fastest-Growing)

In the Blood Grouping Reagents Market, hospitals represent the largest segment, commanding a significant share due to their high demand for blood grouping tests for transfusion and surgery procedures. Diagnostic laboratories also contribute notably, catering to a diverse range of testing needs. Blood banks, however, are rapidly gaining traction as the fastest-growing segment, driven by the increasing importance of maintaining a steady supply of safe blood. Research institutions, while smaller, play a vital role in driving innovation in blood grouping technologies.

Hospitals (Dominant) vs. Blood Banks (Emerging)

Hospitals are a dominant force in the market share due to their extensive usage in transfusion practices and surgery preparations, ensuring compatibility between donors and recipients. Blood banks, on the other hand, are emerging as a critical segment, propelled by advancements in technology and an increased emphasis on inventory management and safety protocols. The growth of blood banks is facilitated by policies encouraging voluntary blood donations and improving blood collection methods. Both sectors are crucial for ensuring adequate blood supply, yet they focus on distinct operations that shape their market influence.

By Product Type: Serological Reagents (Largest) vs. Molecular Reagents (Fastest-Growing)

In the Blood Grouping Reagents Market, Serological Reagents hold the largest market share, driven by widespread usage in blood typing and compatibility testing. This segment's dominance is attributed to its established presence and standardized protocols in clinical settings, making it the preferred choice among healthcare professionals. Meanwhile, Molecular Reagents, although smaller in market share, are gaining traction due to their increasing application in genetic testing and personalization of medicine. This shift is indicative of the evolving landscape of healthcare technologies, positioning Molecular Reagents as an emerging player. Growth trends in the Blood Grouping Reagents Market are closely linked to advancements in diagnostic technologies and rising demand for high-precision results. The ongoing shift towards molecular diagnostics is driven by their ability to detect blood groups with high accuracy and reliability. Additionally, collaborations between reagent manufacturers and technology companies are enhancing product innovations, further propelling the growth of both Serological and Molecular Reagents. Increased awareness of blood safety and the need for accurate blood transfusions also contribute positively to the market dynamics, underscoring the importance of these reagents in clinical applications.

Serological Reagents (Dominant) vs. Blood Grouping Kits (Emerging)

Serological Reagents have established themselves as the dominant force in the market share due to their extensive use and reliability in blood typing and cross-matching procedures. Their robust performance stems from decades of research and development, leading to highly reliable and standardized products that meet stringent regulatory requirements. In contrast, Blood Grouping Kits represent an emerging segment, gaining popularity for their convenience and simplicity, catering to various end-users, including hospitals and clinics with limited laboratory resources. The ease of use and rapid results offered by these kits align with the healthcare sector's demands for efficiency and accuracy, positioning them as a vital component in point-of-care testing and expanding market outreach.

By Technology: Manual Testing (Largest) vs. Automated Testing (Fastest-Growing)

In the Blood Grouping Reagents Market, the technology segment is predominantly characterized by Manual Testing, which presently holds the largest market share. This traditional method has been widely adopted due to its simplicity and affordability, catering primarily to smaller laboratories and facilities. In contrast, Automated Testing is gaining significant traction, driven by advancements in technology and a push towards efficiency, accuracy, and high throughput in larger medical institutions. The growth trends in this sector are seeing a remarkable shift towards more automated solutions due to the increasing demand for faster and more accurate diagnostics. Factors such as a rise in the prevalence of blood-related diseases, improvements in laboratory automation, and the need for enhanced operational efficiency are propelling the growth of Automated Testing, which is poised to be the fastest-growing segment in forthcoming years.

Technology: Manual Testing (Dominant) vs. Automated Testing (Emerging)

Manual Testing remains the dominant method within the Blood Grouping Reagents Market, valued for its reliability and cost-effectiveness. It is often preferred by smaller laboratories due to lower equipment costs and ease of operation, making it especially suitable for settings with limited resources. On the other hand, Automated Testing is emerging as an increasingly vital component of the market. It offers enhanced precision, reduced turnaround time, and the capability to handle higher volumes of samples, which aligns with the growing demand for rapid diagnoses in modern healthcare settings. The shift towards automation is further facilitated by technological innovations that improve workflow efficiency, thereby responding to the needs of a fast-paced medical environment.

By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the Blood Grouping Reagents Market, distribution is largely dominated by direct sales, which account for the majority of transactions. Direct sales allow manufacturers to maintain a strong connection with healthcare providers and ensure a steady delivery pipeline of critical reagents. Online sales, while currently representing a smaller portion of the market, are gaining traction as digital transformation in healthcare accelerates, making purchasing more accessible and convenient for laboratories and clinics.

Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct sales are crucial in the Blood Grouping Reagents Market, representing the primary channel for most suppliers. This approach not only fosters stronger relationships between manufacturers and end-users but also allows for tailored customer service and support. In contrast, online sales are emerging as a significant growth driver in this market. As more customers embrace e-commerce, online platforms provide laboratories and medical facilities with an efficient means to order reagents, enhancing accessibility and potentially lowering costs. The shift towards online sales also reflects broader retail trends, making it essential for traditional suppliers to adapt.

Get more detailed insights about Blood Grouping Reagents Market
Request Free Sample

Regional Insights

North America : Market Leader in Reagents

North America leads in the Blood Grouping Reagents Market Size, accounting for over 53% of the global revenue in 2024. The region's growth is driven by increasing healthcare expenditures, advancements in diagnostic technologies, and a rising prevalence of blood-related disorders. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring compliance and safety in reagent production.

The competitive landscape in North America is robust, featuring key players such as Abbott, Thermo Fisher Scientific, and Bio-Rad Laboratories. These companies are investing heavily in R&D to enhance product offerings and meet the growing demand for accurate blood typing solutions. The presence of established healthcare infrastructure and a focus on improving patient outcomes are pivotal in sustaining market growth in this region.

Europe : Emerging Market Dynamics

Europe's Blood Grouping Reagents Market is projected to reach 0.65 Bn by 2025, driven by increasing awareness of blood safety and stringent regulatory frameworks. The region benefits from a well-established healthcare system and a growing emphasis on personalized medicine, which fuels demand for advanced blood grouping technologies.

Regulatory bodies like the European Medicines Agency (EMA) play a crucial role in ensuring product efficacy and safety, thereby enhancing market confidence. Leading countries such as Germany, France, and the UK are at the forefront of this market, hosting major players like Roche and Siemens Healthineers. The competitive landscape is characterized by strategic collaborations and innovations aimed at improving diagnostic accuracy. As the market evolves, companies are focusing on expanding their product portfolios to cater to diverse healthcare needs across Europe.

Asia-Pacific : Rapidly Growing Market

The Asia-Pacific Blood Grouping Reagents Market is anticipated to grow significantly, reaching 0.25 Bn by 2025. This growth is fueled by increasing healthcare investments, rising incidences of blood disorders, and a growing population. Countries in this region are witnessing a surge in demand for advanced diagnostic solutions, supported by government initiatives aimed at improving healthcare infrastructure and access to quality medical services.

Key players in the Asia-Pacific market include Grifols and Ortho Clinical Diagnostics, who are expanding their presence through strategic partnerships and local manufacturing. Countries like China and India are emerging as significant markets due to their large populations and increasing healthcare needs. The competitive landscape is evolving, with a focus on innovation and affordability to cater to diverse market segments.

Middle East and Africa : Developing Market Potential

The Middle East and Africa Blood Grouping Reagents Market is projected to reach 0.14 Bn by 2025, driven by increasing healthcare investments and a growing awareness of blood safety. The region is experiencing a gradual shift towards modern healthcare practices, with governments prioritizing healthcare infrastructure development.

Regulatory bodies are beginning to implement stricter guidelines, which is expected to enhance the quality and safety of blood grouping reagents in the market. Countries like South Africa and the UAE are leading the way in adopting advanced diagnostic technologies. The competitive landscape is characterized by a mix of local and international players, including Merck KGaA and Beckman Coulter. As the market matures, there is a growing emphasis on innovation and partnerships to address the unique healthcare challenges faced in this region.

Blood Grouping Reagents Market Regional Image

Key Players and Competitive Insights

The Blood Grouping Reagents Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansions. Key players such as Grifols (ES), Roche (CH), and Abbott (US) are actively pursuing strategies that emphasize technological advancements and operational efficiencies. Grifols (ES) has focused on enhancing its product portfolio through research and development, while Roche (CH) has been investing in digital transformation initiatives to streamline operations and improve customer engagement.
 
Abbott (US) appears to be leveraging its strong market presence to expand into emerging markets, thereby diversifying its revenue streams and enhancing its competitive positioning.The market structure is moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is particularly relevant in the context of global economic fluctuations. The collective influence of these major players contributes to a dynamic competitive environment, where agility and responsiveness to market demands are crucial for success.
 
In November Roche (CH) announced the launch of a new line of blood grouping reagents designed to enhance the accuracy and speed of blood typing processes. This strategic move is significant as it not only reinforces Roche's commitment to innovation but also positions the company to capture a larger share of the market by addressing the growing demand for rapid and reliable blood testing solutions.
 
In October Abbott (US) entered into a strategic partnership with a leading biotechnology firm to co-develop next-generation blood grouping reagents. This collaboration is likely to enhance Abbott's research capabilities and accelerate the introduction of innovative products, thereby strengthening its competitive edge in the market. Such partnerships are indicative of a broader trend where companies are increasingly seeking synergies to drive growth and innovation.
 
In September Grifols (ES) expanded its manufacturing capabilities by investing in a new facility in Eastern Europe, aimed at increasing production capacity for blood grouping reagents. This expansion is strategically important as it not only enhances Grifols' operational efficiency but also positions the company to better serve the growing demand in the region, reflecting a proactive approach to market dynamics.
 
As of December current competitive trends in the Blood Grouping Reagents Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development and operational processes. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition towards innovation, technological advancements, and supply chain reliability, which are becoming paramount in maintaining a competitive advantage.

Key Companies in the Blood Grouping Reagents Market include

Industry Developments

  • In July 2020, Merck KGaA invested 18 million euros in new life science laboratory in Switzerland. The laboratory facility is to be built in Buchs (Switzerland) to support the growth of the company in the reference materials.
  • In April 2018, Quotient Limited received FDA approval for U.S. commercialization of seven new blood bank reagents.
  • In December 2017, Beckman Coulter, Inc. expanded its development & manufacturing facility based in Lismeehan, County Clare (Ireland). At this facility, the company develops and manufactures reagents used in clinical chemistry, hematology, and immunochemistry product.

Future Outlook

Blood Grouping Reagents Market Future Outlook

The Blood Grouping Reagents Market size is projected to reach USD 4.63 Million by 2035, growing at a CAGR of 7.47%, driven by technological advancements, increasing demand for blood transfusions, and rising awareness of blood safety.

New opportunities lie in:

  • Development of automated blood grouping systems for laboratories. Expansion into emerging markets with tailored reagent solutions. Partnerships with hospitals for integrated blood testing services.

By 2035, the Blood Grouping Reagents Market is expected to achieve substantial growth and innovation.

Market Segmentation

Blood Grouping Reagents Market End Use Outlook

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Research Institutions

Blood Grouping Reagents Market Technology Outlook

  • Manual Testing
  • Automated Testing
  • Microarray Technology

Blood Grouping Reagents Market Application Outlook

  • Blood Typing
  • Transfusion Medicine
  • Organ Transplantation
  • Paternity Testing

Blood Grouping Reagents Market Product Type Outlook

  • Serological Reagents
  • Molecular Reagents
  • Blood Grouping Kits
  • Control Reagents

Blood Grouping Reagents Market Distribution Channel Outlook

  • Direct Sales
  • Online Sales
  • Distributors

Report Scope

MARKET SIZE 2024 2.09(USD Million)
MARKET SIZE 2025 2.27(USD Million)
MARKET SIZE 2035 4.63(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.47% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Grifols (ES), Roche (CH), Abbott (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Ortho Clinical Diagnostics (US), Beckman Coulter (US), Merck KGaA (DE), Siemens Healthineers (DE)
Segments Covered Application, End Use, Product Type, Technology, Distribution Channel
Key Market Opportunities Advancements in automation and digitalization enhance efficiency in the Blood Grouping Reagents Market.
Key Market Dynamics Rising demand for accurate blood typing drives innovation and competition among blood grouping reagent manufacturers.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Blood Grouping Reagents Market by 2035?

The Blood Grouping Reagents Market is projected to reach a valuation of 4.63 USD Million by 2035.

What was the market valuation of the Blood Grouping Reagents Market in 2024?

In 2024, the Blood Grouping Reagents Market was valued at 2.09 USD Million.

What is the expected CAGR for the Blood Grouping Reagents Market during the forecast period 2025 - 2035?

The expected CAGR for the Blood Grouping Reagents Market during the forecast period 2025 - 2035 is 7.47%.

Which companies are considered key players in the Blood Grouping Reagents Market?

Key players in the Blood Grouping Reagents Market include Grifols, Roche, Abbott Laboratories, and Thermo Fisher Scientific.

What are the main applications of Blood Grouping Reagents?

The main applications of Blood Grouping Reagents include Blood Typing, Transfusion Medicine, Organ Transplantation, and Paternity Testing.

How does the market segment by end use look in terms of valuation?

By end use, Hospitals are projected to reach 1.85 USD Million, while Blood Banks are expected to reach 1.39 USD Million.

What types of products are included in the Blood Grouping Reagents Market?

The Blood Grouping Reagents Market includes Serological Reagents, Molecular Reagents, Blood Grouping Kits, and Control Reagents.

What technological advancements are influencing the Blood Grouping Reagents Market?

Technological advancements such as Automated Testing and Microarray Technology are influencing the Blood Grouping Reagents Market.

What distribution channels are utilized in the Blood Grouping Reagents Market?

Distribution channels in the Blood Grouping Reagents Market include Direct Sales, Online Sales, and Retail Pharmacies.

What is the projected growth trend for the Blood Grouping Reagents Market?

The Blood Grouping Reagents Market is expected to experience robust growth, with a projected valuation increase from 2.09 USD Million in 2024 to 4.63 USD Million by 2035.
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included:

Regulatory & Standards Bodies:

US Food and Drug Administration (FDA) - Center for Biologics Evaluation and Research (CBER)

European Medicines Agency (EMA) - Blood and Plasma-derived Medicinal Products

International Council for Commonality in Blood Banking Automation (ICCBBA)

American Association of Blood Banks (AABB)

European Blood Alliance (EBA)

World Health Organization (WHO) - Blood Transfusion Safety Programme

National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)

Centers for Disease Control and Prevention (CDC) - Blood Safety Division

Health Canada - Biologics and Genetic Therapies Directorate

Therapeutic Goods Administration (TGA) - Australia

Pharmaceuticals and Medical Devices Agency (PMDA) - Japan

Industry & Professional Associations:

International Society of Blood Transfusion (ISBT)

American Society of Hematology (ASH)

British Blood Transfusion Society (BBTS)

Asian Association of Transfusion Medicine (AATM)

America's Blood Centers (ABC)

Plasma Protein Therapeutics Association (PPTA)

International Plasma and Fractionation Association (IPFA)

Academic & Research Databases:

National Center for Biotechnology Information (NCBI/PubMed)

Cochrane Library - Transfusion Medicine Reviews

Transfusion Medicine Reviews Journal

Vox Sanguinis Journal

Blood Transfusion Journal

ISBT Science Series

Government & Healthcare Statistics:

Organization for Economic Co-operation and Development (OECD) - Health Statistics

EU Eurostat Health Database

National Center for Health Statistics (NCHS) - Blood Donation and Transfusion Data

WHO Global Health Observatory - Blood Safety Indicators

National Health Service (NHS) Blood and Transplant - UK Statistics

National Blood Authority - Australia

These sources were used to collect blood donation statistics, transfusion volumes, regulatory approval data for blood grouping reagents, clinical safety studies, demographic trends in blood disorders, and market landscape analysis for serological reagents, molecular reagents, blood grouping kits, and control reagents.

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process.

The supply-side sources consist of CEOs, VPs of Product Development, regulatory affairs chiefs, quality control directors, and commercial directors from blood grouping reagent manufacturers, in-vitro diagnostic (IVD) companies, and OEM suppliers.

Blood bank medical directors, transfusion medicine specialists, clinical laboratory managers, hospital hematology department heads, procurement leads from hospitals and diagnostic laboratories, and research institution principal investigators constituted demand-side sources. Market segmentation was validated across consumables and instruments, product pipeline timelines for PCR-based techniques, microarray technologies, and automated testing platforms were confirmed through primary research, and insights on clinical adoption patterns, pricing strategies, tender dynamics, and blood safety compliance requirements were extracted.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (32%), Europe (29%), Asia-Pacific (28%), Rest of World (11%)

Market Size Estimation

Global market valuation was derived through revenue mapping and procedure volume analysis. The methodology included:

Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America including Grifols, Roche, Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Beckman Coulter, Merck KGaA, and Siemens Healthineers

Product mapping across serological reagents, molecular reagents, blood grouping kits, control reagents, and automated instruments

Analysis of reported and modeled annual revenues specific to blood grouping reagent portfolios

Coverage of manufacturers representing 72-78% of global market share in 2024

Extrapolation using bottom-up (blood transfusion volume × reagent consumption rate × ASP by country) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations for hospitals, blood banks, diagnostic laboratories, and research institutions

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035